As shown in Figure 2A, the percentage of apoptotic cells by annexin V-FITC assay was increased in 4-MD-treated osteosarcoma cells as compared to control in a dose dependent manner (Supplementary Figure 1A). This evidence concerns the gene ANXA5 and osteosarcoma.